Personalized cancer treatment using tumor testing and artificial intelligence

This trial uses a technology called xDRIVE Functional Precision Medicine to analyze your tumor and recommend personalized treatment options based on how your specific cancer responds to different drugs. The xDRIVE platform combines tumor testing with artificial intelligence to help doctors find the best treatment for your individual cancer, rather than using a one-size-fits-all approach. Early results show that patients who received treatment recommendations from this approach had significantly longer periods where their cancer did not grow compared to standard treatment.

Many cancer patients, especially in rural and underserved communities in Florida, struggle to access advanced, personalized cancer treatments due to cost, insurance barriers, and distance from specialized cancer centers. This trial aims to bring cutting-edge personalized medicine directly to Florida patients so they have a better chance of finding an effective treatment when their cancer returns or stops responding to standard therapy.